iVeena Delivery Systems Announces Strategic Leadership Promotions to Accelerate Growth and Scientific Innovation [Yahoo! Finance]
Glaukos Corporation (GKOS)
Last glaukos corporation earnings: 2/27 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.glaukos.com/investors/investor-overview/default.aspx
Company Research
Source: Yahoo! Finance
pharmacologic therapies for refractive eye diseases, today announced key executive promotions designed to strengthen operational leadership and advance its scientific vision. Effective immediately, Michael Burr, M.B.A., M.S. , has been promoted to Chief Operating Officer (COO) , and Sarah Molokhia, R.Ph., Ph.D. , has been promoted to Chief Scientific Officer (CSO) . Long time company COO Ned Weinshenker, Ph.D., is moving into the role of Vice President of Chemistry, Manufacturing, & Controls (CMC). These strategic promotions reflect iVeena's commitment to scaling its organizational capabilities and accelerating development of its lead asset, IVMED-85, a first-in-class investigational eye drop for pediatric myopia. The timing of the promotions coincides with the anticipated initiation of a Phase 1 study in healthy adult volunteers. iVeena previously had a positive engagement with the FDA resulting in an open investigational new drug (IND) application for the program. Study enrollment
Show less
Read more
Impact Snapshot
Event Time:
GKOS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GKOS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GKOS alerts
High impacting Glaukos Corporation news events
Weekly update
A roundup of the hottest topics
GKOS
News
- Glaukos (NYSE:GKOS) was upgraded by analysts at William Blair to a "strong-buy" rating.MarketBeat
- A Look At Glaukos (GKOS) Valuation After FDA Label Expansion For iDose TR [Yahoo! Finance]Yahoo! Finance
- Assessing Glaukos (GKOS) After Recent Share Price Rebound And DCF Upside Potential [Yahoo! Finance]Yahoo! Finance
- How Investors May Respond To Glaukos (GKOS) FDA-Backed Repeat Protocol For iDose TR Implant [Yahoo! Finance]Yahoo! Finance
- Director Sells GKOS 15,000 Shares for $1.9 Million [Yahoo! Finance]Yahoo! Finance
GKOS
Earnings
- 10/29/25 - Beat
GKOS
Sec Filings
- 1/26/26 - Form 4
- 1/26/26 - Form 4
- 1/23/26 - Form 4
- GKOS's page on the SEC website